+80%

est. 2Y upside i

HealthcareSeries A

AI Clinical Assistant for Doctors

Rank

#588

Sector

Healthtech

Est. Liquidity

~4Y

Data Quality

Data: Low

Despite a low entry valuation, the severe preference overhang (97%) and stale mark from 2021 make the equity upside for a new employee modest (expected ~80% over 2 years).

Last updated: July 19, 2026

Bull (20%)+211%

Bot MD achieves category leadership in Southeast Asian healthtech, with an IPO window opening in 2027. Revenue reaches $4.5M by 2028, and the market applies a 5x multiple, valuing equity at $22.5M for a 211% upside net of dilution.

Base (55%)+79%

The company continues steady growth in its niche, reaching $4.5M revenue by 2028. A 3x multiple in line with mature healthtech peers implies a $13.5M valuation, yielding 78.5% upside after dilution.

Bear (25%)-21%

Growth slows as large incumbents (Google, Microsoft) or EHR vendors integrate competing AI features. Revenue reaches only $4.5M but the multiple compresses to 1.5x, implying $6.75M valuation, a -20.7% net loss for common after dilution.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

97%

Total preferred liquidation preference of $6.6M represents 97% of current valuation, leaving minimal common equity value.

Dilution Risk

high

The company hasn't raised since 2021; with $2.3M revenue and 27 employees, additional funding is likely within 2 years, diluting common by ~20%.

Secondary Liquidity

none

No secondary market activity detected; no tender offers.

Questions to Ask at the Interview

Strategic questions based on Bot MD's data — designed to show you've done your homework.

  • 1

    How does Bot MD plan to compete with AI capabilities from major cloud providers?

  • 2

    What is the company's go-to-market strategy for expanding beyond Southeast Asia?

  • 3

    Given the 5-year gap since the last funding round, what is the company's cash runway and plans for future fundraising?

Community

Valuation Sentiment

Our model estimates +80% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.